Transforming Health Care Through Evidence and Collaboration
Transforming Health Care Through Evidence and Collaboration
HomeCategories

During this webinar, panelists will discuss opportunities and challenges in the generic and biosimilar market, how past administrations have approached this issue, and the impact on different stakeholders, including consumers.

Alliance-June-Webinar-Image

This webinar explored recent trends in drug prices and outlined leading policy ideas for addressing the crisis.

This interactive website, produced by the Investigative Reporting Workshop and based on two FRONTLINE documentaries, educates the public on antimicrobial resistance.

With grant support from NIHCM Foundation, researchers at the University of Maryland have used big data and machine learning to identify risk factors for chronic opioid use. Using those risk factors, they developed precision decision-support tools for prescribing physicians. On this webinar, the researchers discussed their work, its applications, and next steps for bringing these tools into practice.

Zack Cooper, Stuart Craig, Martin Gaynor & John Van Reenen

This comprehensive analysis of claims data from three national insurers documents the extensive variation in the prices that hospitals receive for the same procedure. Payment rates vary not only across and within hospital markets but also within individual hospitals, suggesting that the relative bargaining power of hospitals and insurers plays a role in price determination. The work also establishes that monopoly hospitals are paid higher prices and are more likely to obtain contracts that place them at lower financial risk, whereas hospital prices are lower and contracts are more likely to be based on prospectively determined rates when the insurer market is more concentrated. Finally, analysis of hospital mergers over a five-year period demonstrates post-merger hospital price increases, with the largest impact observed when merging facilities are in closer proximity to one another.